The Future of Prescription Drugs: Assessing Value

April 19, 2017
Washington, DC

As Washington debates how to reshape health care and Americans struggle to pay for lifesaving drugs, The Atlantic hosted a discussion focused on exploring value-based drug pricing. The Future of Prescription Drugs: Assessing Value convened leading health policy thinkers and practitioners to grapple with how to strike the balance between managing drug prices without stifling innovation.  We explored how the principles of value-based programs — which reward health care providers based on quality of care as measured by patient outcomes — can be applied to pharmaceuticals.

Watch full session videos

To view photos from this event, please visit our Facebook page

Presented by

Atlantic Live


  • Henry Aaron
    Henry Aaron Bruce and Virginia MacLaury Senior Fellow Brookings Institution
  • Gerard Anderson
    Gerard Anderson Professor of Health Policy and Management Johns Hopkins University Bloomberg School of Public Health
  • Alan Balch
    Alan Balch CEO National Patient Advocate Foundation
  • Steve Clemons
    Steve Clemons Washington Editor at Large The Atlantic
  • Gregory Daniel*
    Gregory Daniel* Deputy Director Duke-Margolis Center for Health Policy
  • Susan Dentzer
    Susan Dentzer President and CEO Network for Excellence in Health Innovation
  • Elizabeth Fowler
    Elizabeth Fowler Vice President for Global Health Policy Johnson & Johnson
  • Mark Nagy*
    Mark Nagy* Vice President, Global Patient Outcomes & Real World Evidence Eli Lilly and Company
  • Eleanor Perfetto*
    Eleanor Perfetto* Senior Vice President of Strategic Initiatives National Health Council
  • Amy Comstock Rick
    Amy Comstock Rick President and CEO Food and Drug Law Institute
  • Andrew von Eschenbach
    Andrew von Eschenbach President, Samaritan Health Initiatives; former Commissioner, Food and Drug Administration
  • Alex Wagner
    Alex Wagner Contributing Editor The Atlantic
  • Gail Wilensky
    Gail Wilensky Senior Fellow and Economist Project HOPE
  • Tonya Winders
    Tonya Winders President and CEO Allergy & Asthma Network


  • Wednesday, April 19
  • 8:30 a.m.WelcomeMargaret Low, President, AtlanticLIVE
  • 8:35 a.m.Demystifying Drug PricingHenry Aaron, Bruce and Virginia MacLaury Senior Fellow, Brookings Institution
    Elizabeth Fowler, Vice President for Global Health Policy, Johnson & Johnson
    Gail Wilensky, Senior Fellow and Economist, Project HOPE
    With Steve Clemons, Washington Editor at Large, The Atlantic
  • 9:15 a.m.The Patient Experience and Value-Based Drug PricingAlan Balch, CEO, National Patient Advocate Foundation
    Susan Dentzer, President and CEO, Network for Excellence in Healthcare Innovation
    Tonya Winders, President and CEO, Allergy & Asthma Network
    With Alex Wagner, Contributing Editor, The Atlantic
  • 9:45 a.m.The Role of RegulationGerard Anderson, Professor of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health
    Amy Comstock Rick, President and CEO, Food and Drug Law Institute
    Andrew von Eschenbach, President, Samaritan Health Initiatives; Former Commissioner, Food and Drug Administration
    With Steve Clemons, The Atlantic
  • 10:15 a.m.Closing ThoughtsMargaret Low, AtlanticLIVE


Upcoming Events

  • Health Care

    Cancer and the Community

    The Atlantic will explore challenges such as Nevada's shortage of doctors and specialists and learn what can be done from researchers, experts, stakeholders, survivors and patients living with cancer.

  • Politics

    Defining Justice:
    The Experience of Women and Children Behind Bars

    As Oklahoma grapples with an emerging political consensus around criminal justice reform, The Atlantic will seek to understand the experiences of women affected by the state’s justice system.

  • Washington Ideas

    For its ninth year, the Washington Ideas Forum will convene the nation's leaders, from politics and government to business and culture for two days of idea sharing and thought provoking conversation.